To investigate whether MKX-AS1 and MKX expression status is associated with patient outcomes, a Kaplan–Meier survival analysis was assessed for overall survival (OS) of patients with CRC tumors and gene expression from the Cancer Genome Atlas (TCGA) dataset. This evidence concerns the gene MKX and colorectal carcinoma.